William G Skelly insider trades: Acura Pharmaceuticals (ACUR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where William reports to the SEC
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 14, 2017 | ACUR | ↑ Buy | 100,000 | $0.10 | $10K | Direct | Dec 18, 2017 (4d) |
| May 22, 2014 | ACUR | ↓ Sell | 4,600 | $1.23 | $6K | Direct | May 22, 2014 (0d) |
| May 20, 2014 | ACUR | ↓ Sell | 5,000 | $1.21 | $6K | Direct | May 21, 2014 (1d) |
| May 14, 2014 | ACUR | ↓ Sell | 2,900 | $1.21 | $4K | Direct | May 16, 2014 (2d) |
| May 12, 2014 | ACUR | ↓ Sell | 5,000 | $1.25 | $6K | Direct | May 13, 2014 (1d) |
| May 8, 2014 | ACUR | ↓ Sell | 2,500 | $1.30 | $3K | Direct | May 9, 2014 (1d) |
| Aug 27, 2013 | ACUR | ↓ Sell | 2,000 | $1.55 | $3K | Direct | Aug 28, 2013 (1d) |
| May 28, 2013 | ACUR | ↓ Sell | 2,000 | $2.40 | $5K | Direct | May 29, 2013 (1d) |
| May 22, 2013 | ACUR | ↓ Sell | 4,000 | $2.33 | $9K | Direct | May 23, 2013 (1d) |
| May 16, 2013 | ACUR | ↓ Sell | 3,000 | $2.25 | $7K | Direct | May 20, 2013 (4d) |
| May 9, 2013 | ACUR | ↓ Sell | 3,000 | $2.20 | $7K | Direct | May 13, 2013 (4d) |
| Apr 3, 2013 | ACUR | ↓ Sell | 6,000 | $2.04 | $12K | Direct | Apr 4, 2013 (1d) |
| Mar 7, 2013 | ACUR | ↓ Sell | 5,000 | $2.52 | $13K | Direct | Mar 7, 2013 (0d) |
| Nov 27, 2012 | ACUR | ↓ Sell | 5,341 | $1.25 | $7K | Direct | Nov 28, 2012 (1d) |
| Nov 15, 2012 | ACUR | ↓ Sell | 4,659 | $1.15 | $5K | Direct | Nov 16, 2012 (1d) |
| Nov 9, 2012 | ACUR | ↓ Sell | 5,000 | $1.28 | $6K | Direct | Nov 13, 2012 (4d) |
| May 7, 2012 | ACUR | ↓ Sell | 5,000 | $3.00 | $15K | Direct | May 7, 2012 (0d) |
| Mar 12, 2012 | ACUR | ↓ Sell | 5,000 | $4.12 | $21K | Direct | Mar 21, 2012 (9d) |
| Mar 12, 2012 | ACUR | ↓ Sell | 5,000 | $3.30 | $17K | Direct | Mar 13, 2012 (1d) |
| Nov 8, 2011 | ACUR | ↓ Sell | 2,213 | $3.90 | $9K | Direct | Nov 9, 2011 (1d) |
| Nov 7, 2011 | ACUR | ↓ Sell | 7,787 | $3.90 | $30K | Direct | Nov 9, 2011 (2d) |
| May 9, 2011 | ACUR | ↓ Sell | 5,000 | $4.27 | $21K | Direct | May 9, 2011 (0d) |
| Jan 9, 2011 | ACUR | ↓ Sell | 5,000 | $3.16 | $16K | Direct | Mar 10, 2011 (60d) |
| Mar 17, 2010 | ACUR | ↓ Sell | 1,000 | $5.55 | $6K | Direct | Mar 18, 2010 (1d) |
| Nov 14, 2008 | ACUR | ↓ Sell | 3,200 | $5.01 | $16K | Direct | Nov 17, 2008 (3d) |
| Nov 7, 2007 | ACUR.OB | ↓ Sell | 68,000 | $1.52 | $104K | Direct | Nov 9, 2007 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About William G Skelly's insider trades
William G Skelly is a director at Acura Pharmaceuticals (ACUR). Since Nov 7, 2007, William has reported 1 open-market purchase worth $10K and 25 sales worth $352K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (20 filings), option exercises (13 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACUR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.